Preview

Вестник медицинского института «РЕАВИЗ». Реабилитация, Врач и Здоровье

Расширенный поиск

Дивертикулярная болезнь толстого кишечника: современное состояние проблемы

https://doi.org/10.20340/vmi-rvz.2020.4.3

Полный текст:

Аннотация

В данном обзоре приведены современные сведения об этиопатогенезе, клинике, диагностике и лечении дивертикулярной болезни толстого кишечника (ДБТК). На основании проведенного анализа и эпидемиологических данных данную патологию можно отнести к глобальной эпидемии 21 века, ассоциированной с вестернизацией образа жизни и постарением населения в цивилизованных странах. Описанная тактика ведения больных с данной патологией базируется на мировых тенденциях, сформировавшихся в последнее десятилетие.

Об авторах

Н. А. Лысов
Частное учреждение образовательная организация высшего образования «Медицинский университет Реавиз»
Россия

Лысов Николай Александрович - доктор медицинских наук, профессор, ректор

Самара



М. М. Осадчук
Частное учреждение образовательная организация высшего образования «Медицинский университет Реавиз»; ГБУЗ г. Москвы «Городская поликлиника № 52 Департамента здравоохранения города Москвы»
Россия

Осадчук Максим Михайлович - кандидат медицинских наук, доцент кафедры клинической медицины; заведующий отделом организационно-методической и клинико-экспертной работы

Самара

Москва



Д. В. Балашов
ГБУЗ г. Москвы «Городская поликлиника № 52 Департамента здравоохранения города Москвы»
Россия

Балашов Дмитрий Владимирович - кандидат медицинских наук, Главный врач

Москва



Список литературы

1. Peery A.F., Crockett S.D., Murphy C.C. et al. Burden and cost of gastrointes-tinal, liver, and pancreatic diseases in the United States: update 2018. Gas-troenterology. 2019; 156:254–272.e11.

2. Osadchuk M.A., Svistunov A.A., Zolotovitskaya A.M. and others. Diverticular disease of the large intestine and its association with polyps and colorectal cancer: clinical-instrumental and immunomorphological research // North Cau-casus Medical Newsletter. – 2020. – № 1. – С. 52–57.

3. Everhart J.E., Ruhl C.E. Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. Gastroenterology. 2009;136:741–754.

4. Michael Camilleri, Robert S. Sandler, Anne F. Peery. Etiopathogenetic Mecha-nisms in Diverticular Disease of the Colon. Cell Mol Gastroenterol Hepatol. 2020; 9(1): 15–32. Published online 2019 Jul 25. doi: 10.1016/j.jcmgh.2019.07.007 PMCID: PMC6881605

5. Rafferty J, Shellito P, Hyman NH, Buie WD. Practice parameters for sigmoid diverticulitis. Dis Colon Rectum. 2006;49(7):939–44. doi: 10.1007/s10350-006-0578-2.

6. Nguyen GC, Sam J, Anand N. Epidemiological trends and geographic variation in hospital admissions for diverticulitis in the United States. World J Gastro-enterol. 2011;17(12):1600–1605.

7. Etzioni DA, Mack TM, Beart RW, Jr, et al. Diverticulitis in the United States: 1998–2005: Changing patterns of disease and treatment. Ann Surg 2009; 249: 210–217.

8. Delvaux M. Diverticular disease of the colon in Europe: Epidemiology, impact on citizen health and prevention. Aliment PharmacolTher 2003; 18: S71–S74.

9. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–1511.

10. Alatise OI, Arigbabu AO, Agbakwuru EA, et al. Spectrum of colonoscopy find-ings in Ile-Ife Nigeria. Niger Postgrad Med J 2012; 19: 219–224.

11. Strate L. L. Diverticulosis and dietary fiber: rethinking the relationship. Gastroenterology 142, 205–207 (2012).

12. Meurs-Szojda M. M., Terhaar sive Droste J. S., Kuik D. J.,Mulder C. J. J., Felt-Bersma R. J. F. Diverticulosis and diverticulitis form no risk for polyps and colorectal neoplasia in 4,241 colonoscopies. Int. J. Colorectal. Dis.2008;23(10):979-984. https://doi.org/10.1007/s00384-008-0510-4

13. Regula J. Diverticular Disease and Colorectal Cancer: Incidental Diagnosis or Real Association? Final Answer. J. Clin. Gastroenterol. 2016;50 Suppl.1:S39-40.https://doi.org/10.1097/MCG.0000000000000643

14. Jansen A. Risk factors for colonic diverticular bleeding: A westernized com-munity-based hospital study. World J Gastroenterol 2009; 15: 457–457

15. Jansen A. Risk factors for colonic diverticular bleeding: A westernized com-munity-based hospital study. World J Gastroenterol 2009; 15: 457–457

16. Strate L.L., Morris A.M. Epidemiology, pathophysiology, and treatment of di-verticulitis. Gastroenterology. 2019;156:1282–1298.e1.

17. Daniels L., Philipszoon L.E., Boermeester M.A. A hypothesis: important role for gut microbiota in the etiopathogenesis of diverticular disease. Dis Colon Rectum. 2014;57:539–543.

18. Nguyen L.H., Cao Y., Ma W., Jovani M., Liu P.-H., Huttenhower C., Ludvigsson J.F., Wu K., Giovannucci E., Strate L.L., Chan A.T. Chronic antibiotic use and subsequent development of diverticulitis. Gastroenterology. 2019;156(Suppl 1):S1155.

19. Walker MM, Harris AK. Pathogenesis of diverticulosis and diverticular dis-ease. Minerva GastroenterolDietol. 2016 Dec 14.

20. Wedel T, Barrenschee M, Lange C, Cossais F, Böttner M. Morphologic Basis for Developing Diverticular Disease, Diverticulitis, and Diverticular Bleeding. Viszeralmedizin. 2015 Apr;31(2):76-82. doi: 10.1159/000381431. Review.

21. Scarpignato C, Barbara G, Lanas A, et al. Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017. Therap Adv Gastroenterol 2018; 11: 1756284818771305–1756284818771305.

22. Tursi A, Elisei W, Giorgetti GM, et al. Inflammatory manifestations at colon-oscopy in patients with colonic diverticular disease. AlimentPharmacolTher 2011; 33: 358–365.

23. Diverticular disease of the large intestine / A.A. Svistunov, M.A. Osadchuk, D.V. Bala-shev, M.M. Osadchuk. – M.: RAMS Publishing House, 2017. – 52 р.

24. Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study. Antonio Tursi,corresponding author / G. Brandimarte [et al.] // United European Gastroenterol J. 2016 Aug; 4(4): 604–613.

25. Tursi A, Brandimarte G, Di Mario F, et al. Development and validation of an endoscopic classification of diverticular disease of the colon: The DICA classification. DigDis 2015; 33: 68–76.

26. Gallo A1, Ianiro G, Montalto M, Cammarota G. The Role of Biomarkers in Diver-ticular Disease. J ClinGastroenterol. 2016 Oct;50 Suppl 1:S26-8. doi: 10.1097/MCG.0000000000000648.

27. Tursi A. New physiopathological and therapeutic approaches to diverticular disease: An update. ExpertOpinPharmacother 2014; 15: 1005–1017.

28. Cuomo R, Barbara G, Andreozzi P, et al. Symptom patterns can distinguish di-verticular disease from irritable bowel syndrome. Eur J Clin Invest 2013; 43: 1147–1155.

29. Bevan R, Lee TJ, Nickerson C, et al. Non-neoplastic findings at colonoscopy after positive faecal occult blood testing: Data from the English Bowel Can-cer Screening Programme. J Med Screen 2014; 21: 89–94

30. Scarpignato C, Barbara G, Lanas A, et al. Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017. Therap Adv Gastroenterol 2018; 11: 1756284818771305–1756284818771305.

31. Carabotti M, Annibale B. Treatment of diverticular disease: An update on lat-est evidence and clinical implications. Drugs Context 2018; 7: 212526–212526.

32. Carmelo Scarpignato, Giovanni Barbara, Angel Lanas, Lisa L. Strate. Manage-ment of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017. Therap Adv Gastroenterol. 2018; 11: 1756284818771305. Published online 2018 May 20. doi: 10.1177/1756284818771305

33. Tandon A, Fretwell VL, Nunes QM, et al. Antibiotics versus no antibiotics in the treatment of acute uncomplicated diverticulitis - a systematic review and meta-analysis. Colorectal Dis. Epub ahead of print 11 January 2018. DOI: 10.1111/codi.14013

34. Gargallo Puyuelo CJ, Sopena F, Lanas Arbeloa A. Colonic diverticular disease. Treatment and prevention. Gastroenterol Hepatol 2015; 38: 590–599.

35. Barbara G, Cremon C, Barbaro MR, et al. Treatment of diverticular disease with aminosalicylates: the evidence. J Clin Gastroenterol 2016; 50(Suppl. 1): S60–S63.

36. Barbara G, Scaioli E, Barbaro MR, et al. Gut microbiota, metabolome and im-mune signatures in patients with uncomplicated diverticular disease. Gut 2017; 66: 1252–1261.

37. Humes DJ, Spiller RC. Review article: the pathogenesis and management of acute colonic diverticulitis. Aliment Pharmacol Ther 2014; 39: 359–370.

38. Cuomo R, Barbara G, Annibale B. Rifaximin and diverticular disease: position paper of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 2017; 49: 595–603.

39. Italian consensus conference for colonic diverticulosis and diverticular dis-ease. Rosario Cuomo,corresponding author1 Giovanni Barbara,2 Fabio Pace,3 Vi-to Annese,4 Gabrio Bassotti,5 Gian Andrea Binda,6 Tino Casetti,7 Antonio Colecchia,2 Davide Festi,2 Roberto Fiocca,8 Andrea Laghi,9 Giovanni Maconi,10 Riccardo Nascimbeni,11 Carmelo Scarpignato,12 Vincenzo Villanacci,13 and Bru-no Annibale14. United European Gastroenterol J. 2014 Oct; 2(5): 413–442. doi: 10.1177/2050640614547068

40. Strate L.L., Liu Y.L., Aldoori W.H., et al. Physical activity decreases di-verticular complications. Am JGastroenterol 2009; 104:1221-30.

41. Strate L.L., Liu M.S., Aldoori W.H., et al. Obesity increases the risk of di-verticulitis and diverticular bleeding. Gastroenterology 2009; 136(1):115-22.


Для цитирования:


Лысов Н.А., Осадчук М.М., Балашов Д.В. Дивертикулярная болезнь толстого кишечника: современное состояние проблемы. Вестник медицинского института «РЕАВИЗ». Реабилитация, Врач и Здоровье. 2020;(4):33-41. https://doi.org/10.20340/vmi-rvz.2020.4.3

For citation:


Lysov N.A., Osadchuk M.M., Balashov D.V. Diverticular disease of the large intestine: current state of the problem. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH). 2020;(4):33-41. (In Russ.) https://doi.org/10.20340/vmi-rvz.2020.4.3

Просмотров: 14


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2226-762X (Print)
ISSN 2782-1579 (Online)